Selective inhibition of collagenase-1, gelatinase A, and gelatinase B by chemotherapeutic agents.
Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.
U
U
Benbow
R
R
Maitra
J W
JW
Hamilton
C E
CE
Brinckerhoff
D000111:Acetylcysteine / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D016190:Carboplatin / Q000494:pharmacology; D002945:Cisplatin / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D018093:Gelatinases / Q000037:antagonists & inhibitors*; D006801:Humans; D020781:Matrix Metalloproteinase 1; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D061965:Matrix Metalloproteinase Inhibitors; D008545:Melanoma / Q000473:pathology; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D016685:Mitomycin / Q000494:pharmacology; D009361:Neoplasm Invasiveness / Q000517:prevention & control; D011480:Protease Inhibitors / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D061965:Matrix Metalloproteinase Inhibitors; D011480:Protease Inhibitors; D016685:Mitomycin; D004317:Doxorubicin; D016190:Carboplatin; D018093:Gelatinases; D008666:Metalloendopeptidases; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D020781:Matrix Metalloproteinase 1; D002945:Cisplatin; D000111:Acetylcysteine